Knowledge-to-Action (KTA) Framework

The Designated Institutional Official (DIO) is the individual at an ACGME-accredited Sponsoring Institution who holds institution-wide authority and responsibility for the oversight and administration of every graduate medical education (GME) program the institution sponsors — every residency and fellowship, across every specialty and site — and for the institution’s overall compliance with the Accreditation Council for Graduate Medical Education’s (ACGME) Institutional, Common, and specialty-specific Program Requirements. The DIO is a required position at any institution that sponsors ACGME-accredited training: an institution cannot hold ACGME accreditation without one.

“Designated Institutional Official” is a formally defined GME accreditation role, distinct from the more general term “Institutional Official” used in federal human-subjects and financial-conflict-of-interest compliance (covered in its own section below) — the two are easy to conflate by name but govern different things.

What makes someone the DIO

Operationally, a person holds the DIO role at a given Sponsoring Institution when all of the following are true:

• Appointment by the Sponsoring Institution’s Governing Body. The DIO is appointed by, and accountable to, the institution’s governing body (its board, president, CEO, or equivalent senior leadership structure) — not selected by a single training program or department.
• Authority spans every ACGME-accredited program the institution sponsors. A department chair or single program’s leadership overseeing only their own residency does not meet the definition; the DIO’s authority is institution-wide, covering every Sponsoring Institution program regardless of specialty.
• Named responsibility for ACGME compliance. The DIO is accountable to ACGME for the institution meeting its Institutional Requirements and for each program meeting its Common and specialty-specific Program Requirements — this is the accountability relationship ACGME site visits and accreditation decisions run through.
• Works in collaboration with the GMEC, not in place of it. The DIO holds executive authority and responsibility for oversight and administration, but exercises it in collaboration with the institution’s Graduate Medical Education Committee (GMEC), which the ACGME Institutional Requirements also require to meet at least quarterly and to hold its own oversight responsibilities for the sponsored programs.

The ACGME Institutional Requirements do not mandate that the DIO hold a specific professional credential (there is no requirement that the DIO be a physician), and a single individual may serve as DIO for more than one Sponsoring Institution, provided each institution separately defines the financial support and protected time it commits to that person for DIO responsibilities.

DIO responsibilities and authority

Under the ACGME Institutional Requirements, the DIO’s specific responsibilities typically include:

• Approving each program’s Program Letters of Agreement (PLAs), which govern the relationship between a program and any participating site providing a required rotation or assignment for residents or fellows.
• Overseeing submission of each program’s and the Sponsoring Institution’s required Annual Update to ACGME.
• Overseeing — after GMEC approval — submission of applications for new ACGME accreditation or recognition, requests for voluntary withdrawal of accreditation, and requests to change a program’s resident/fellow complement.
• Approving, together with the GMEC, the appointment of fellows who have not completed an ACGME- or ACGME-International-accredited residency program, in addition to the fellowship program director’s approval.
• Meeting regularly with program directors and with resident/fellow representative bodies, and maintaining the institution’s GME policies and its process for reviewing and acting on programs found not to be in substantial compliance.

DIO vs. “Institutional Official” in research compliance

Research administrators working across both GME and sponsored-research operations should keep two similarly-named but functionally distinct roles apart:

• Designated Institutional Official (DIO) — the GME accreditation role described on this page, defined by ACGME and specific to a Sponsoring Institution’s residency and fellowship programs.
• Institutional Official (IO) — in human-subjects research compliance, the individual authorized to sign an institution’s Federalwide Assurance (FWA) with the HHS Office for Human Research Protections and to obligate the institution to the FWA’s terms, including designating the IRB(s) that will review the institution’s human-subjects research. A closely related, separately regulated use of similar language appears in the PHS financial conflict of interest regulation at 42 CFR 50.604, which requires institutions to route investigator significant financial interest disclosures to the institution’s own designated reviewing official(s) — a review function, not a formally titled “Designated Institutional Official” position.

These are not interchangeable: an institution’s FWA Institutional Official and its GME DIO are frequently different individuals, appointed under different regulatory frameworks (ACGME accreditation standards vs. the Common Rule / FDA human-subjects regulations), reporting on different compliance obligations to different oversight bodies.

Worked examples

• A teaching hospital sponsoring twelve ACGME-accredited residency and fellowship programs across internal medicine, surgery, and pediatrics appoints one senior physician-administrator as DIO. That person is accountable to the hospital’s governing body for GME compliance institution-wide, chairs or co-leads the GMEC, and personally approves every program’s PLAs with affiliated rotation sites — regardless of specialty.
• A multi-hospital health system with a single ACGME Sponsoring Institution designation appoints one DIO who serves across all its component training sites, while each individual residency program still has its own program director handling day-to-day program administration; the DIO’s oversight sits above, not in place of, each program director.

Counter-example

A program director who manages accreditation compliance for their own single residency program, but has no institution-wide authority over other programs and no accountability relationship to ACGME at the Sponsoring Institution level, is not the DIO — that authority sits with whoever the Governing Body has designated for the entire Sponsoring Institution. Likewise, an institution’s IRB chair or its FWA-signing Institutional Official is not, by virtue of that role alone, the institution’s DIO; the two roles arise from separate regulatory schemes and are not automatically held by the same person.

Frequently Asked Questions

What does "KTA" stand for?

KTA stands for Knowledge-to-Action, the name of the framework Ian Graham and colleagues introduced for planning and evaluating knowledge translation (KT) activity.

Who created the Knowledge-to-Action Framework, and when?

Ian Graham and colleagues introduced it in a 2006 paper, ‘Lost in knowledge translation: time for a map?’, published in the Journal of Continuing Education in the Health Professions. The paper synthesised more than 30 existing planned-action and knowledge-use theories into a single applied model.

What are the two components of the KTA Framework?

The KTA Framework has two linked but distinct parts, usually drawn as a funnel sitting inside a cycle: a Knowledge Creation funnel and an Action Cycle. The funnel narrows research knowledge through three phases (inquiry, synthesis, and knowledge tools/products), while the cycle sets out seven phases for putting that knowledge into practice.

What are the seven phases of the KTA Action Cycle?

The Action Cycle’s seven phases are: identify the problem and select relevant knowledge, adapt the knowledge to the local context, assess barriers and facilitators to using the knowledge, select and implement interventions, monitor knowledge use, evaluate the outcomes, and sustain ongoing knowledge use.

Do you have to complete all seven Action Cycle phases to use the KTA Framework?

No. Graham and colleagues describe the phases as dynamic rather than strictly linear, and they can happen in a different order, overlap, or run simultaneously. In practice, most KTA-based projects use only a subset of the seven phases — reviews of published applications consistently find ‘identify the problem’ used almost universally and ‘sustain knowledge use’ reported least often.

How is the KTA Framework different from knowledge translation (KT)?

Knowledge translation is the broader concept — the general process, and CIHR’s definition, of moving research knowledge into use. The KTA Framework is one particular, named model that researchers and funders use to structure and plan that process; a project can practise knowledge translation without ever invoking the KTA Framework by name.